Skip to main content
Account Bag 0

Ozempic face: what it is, and what helps.

The gaunt, lined, slightly deflated look that can follow rapid weight loss on a GLP-1 has two causes at once. Only one of them is something a topical can help with.

APLOMB GLP-1 Resource ยท Reviewed by Zachary Poll, Founder

What is Ozempic face?

Ozempic face is the term for the hollowed, lax, more lined appearance some people notice in the face after fast weight loss on a GLP-1 medication. It is driven by two separate changes happening together: a loss of the fat that gave the face volume, and a decline in the skin's own collagen density and elasticity.

The name attached to one brand, but the pattern is not specific to any single drug. It can follow rapid weight loss from semaglutide, tirzepatide, or any cause. The faster the loss, the more visible it tends to be, because skin and the structures under it do not remodel as quickly as fat disappears.

Why does it happen?

Rapid fat loss removes volume that previously filled and supported the face, while the dermis loses collagen and elastin faster than the body rebuilds them. The result reads as sagging, crepey texture, and deeper lines.

Two distinct problems sit underneath that single appearance. The volume problem is structural: there is simply less fat padding the face. The skin-quality problem is in the dermis itself, where thinning collagen and reduced elasticity make the surface look less firm. Sorting which is which matters, because they have different solutions.

Can anything help the skin itself?

A well-formulated topical can support the skin-quality side, firmness, texture, and fine lines, by supporting collagen in the dermis. It cannot restore lost facial volume.

This is where peptides come in. APLOMB. The Serum is built for the dermal-thinning fraction of GLP-1 facial change. It pairs Matrixyl 3000 and Matrixyl Synthe'6 peptides with four plant actives (Centella, Kakadu Plum, Bearberry, Licorice). In the manufacturer's published testing the peptide system showed a 45 percent reduction in deep wrinkles over eight weeks, and a separate 2023 study reported a 55 percent increase in collagen density over twelve weeks. It is a topical cosmetic, applied AM and PM under SPF.

What this will not do A serum cannot refill lost facial volume. If the concern is hollowing rather than skin quality, that is the domain of dermal fillers or biostimulators, placed by a dermatologist. The Serum supports the skin; it is not a substitute for volume restoration.

What else supports the skin during weight loss?

Losing weight more gradually gives skin more time to adapt, and adequate protein and daily SPF support the dermis through the change.

None of this reverses the volume loss, and honest expectations matter: the goal is to support skin quality and slow visible change, not to promise the face you had before. For volume, see a clinician about fillers or biostimulators.

Citations

  1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021. NEJM full text
  2. Li Y, et al. Clinical evaluation of a peptide complex on collagen density and skin appearance. Journal of Cosmetic Dermatology, 2023.
  3. Sederma. Matrixyl 3000 and Matrixyl Synthe'6 peptide dossiers (manufacturer clinical data on wrinkle depth).

GLP-1 Side Effects: all five, and what helps

Editorial content, not medical advice. APLOMB. The Serum is a topical cosmetic. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. APLOMB is not affiliated with, endorsed by, or sponsored by the makers of any GLP-1 medication; brand names are used for informational purposes only. Talk to a clinician about your skin and any medication.